Spots Global Cancer Trial Database for disease progression
Every month we try and update this database with for disease progression cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN | NCT04115787 | High-Grade Squa... Neoplasm Regres... Disease Progres... Papillomavirus ... | 18 Years - 50 Years | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | ||
| Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas | NCT04346472 | Low-grade Gliom... | Repeated Measur... | 18 Years - | University Hospital, Montpellier | |
| Treatment Resistance Following Anti-cancer Therapies | NCT04436120 | Disease Progres... | De novo tumor t... Research blood ... | 18 Years - | Pfizer | |
| CTFEA Myeloma Study | NCT04364724 | Myeloma Multipl... Metastatic Bone... | CT-based finite... | 18 Years - 95 Years | Tel-Aviv Sourasky Medical Center | |
| Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years | NCT01191060 | Myeloma | Lenalidomide, B... Lenalidomide, B... | 18 Years - 65 Years | University Hospital, Toulouse | |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) | NCT02766699 | Glioblastoma Astrocytoma, Gr... | EGFR(V)-EDV-Dox | 18 Years - | Engeneic Pty Limited | |
| Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer | NCT05297734 | End of Life Cancer | Receive technol... Receive redesig... | 21 Years - | Stanford University | |
| Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer | NCT02817126 | Rectal Carcinom... | Robot-assisted ... Laparoscopic re... | 18 Years - 80 Years | Fudan University | |
| Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis | NCT01684761 | Autoimmune Dise... Multiple Sclero... Secondary Progr... Disease Progres... Brain Atrophy | Tcelna Placebo | 18 Years - 60 Years | Opexa Therapeutics, Inc. | |
| Natural Disease Progress of Dupuytren Disease | NCT01923103 | Dupuytren Contr... Disease Progres... | 18 Years - | University Medical Center Groningen | ||
| Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | NCT01110668 | Gastrointestina... | Nilotinib | 18 Years - | Novartis | |
| Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes | NCT01196715 | Myelodysplastic... | Darbepoetin alp... Filgrastim Blood Red Cell ... | 18 Years - | Barts & The London NHS Trust | |
| CTFEA Myeloma Study | NCT04364724 | Myeloma Multipl... Metastatic Bone... | CT-based finite... | 18 Years - 95 Years | Tel-Aviv Sourasky Medical Center | |
| Parenteral Nutrition Therapy in Patients With Incurable Cancer | NCT04456647 | Neoplasms Terminal Illnes... | Parenteral nutr... | 18 Years - | Norwegian University of Science and Technology | |
| Natural Disease Progress of Dupuytren Disease | NCT01923103 | Dupuytren Contr... Disease Progres... | 18 Years - | University Medical Center Groningen | ||
| Salvage Surgery for Patients With Metastatic GIST With Rego | NCT04343456 | Gastrointestina... Metastasis Disease Progres... | Salvage surgery... | 20 Years - | Chang Gung Memorial Hospital | |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) | NCT02766699 | Glioblastoma Astrocytoma, Gr... | EGFR(V)-EDV-Dox | 18 Years - | Engeneic Pty Limited | |
| Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors | NCT02538432 | Prostate Cancer Non-Small Cell ... Breast Cancer | RQ-00000007 Gemcitabine | 18 Years - | University of Maryland, Baltimore | |
| Predicting Disease Progression and/or Recurrence in Cancer | NCT04776837 | Patient Reporte... Colorectal Canc... Pancreatic Canc... Biliary Tract C... Esophageal Canc... Metastatic Canc... Disease Progres... Survival Analys... | Observational C... | 18 Years - | Massachusetts General Hospital | |
| Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma | NCT04987203 | Renal Cell Carc... | Tivozanib Nivolumab | 18 Years - 130 Years | AVEO Pharmaceuticals, Inc. | |
| Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas | NCT04346472 | Low-grade Gliom... | Repeated Measur... | 18 Years - | University Hospital, Montpellier | |
| Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma | NCT04987203 | Renal Cell Carc... | Tivozanib Nivolumab | 18 Years - 130 Years | AVEO Pharmaceuticals, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
